On Monday, Exelixis, Inc. (NASDAQ:EXEL)’s shares declined -8.12% to $2.83.
Exelixis, Inc. (EXEL) declared that its first quarter 2015 financial results will be released on Thursday, April 30, 2015 after the markets close. At 5:00 p.m. EDT / 2:00 p.m. PDT, Exelixis administration will host a conference call to talk about the results and provide a general business update. The conference call will be accessible via the Internet from the Company’s website.
Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States.
United Therapeutics Corporation (NASDAQ:UTHR)’s shares dropped -7.75% to $172.22.
United Therapeutics Corporation (UTHR) declared its financial results for the first quarter ended March 31, 2015. Martine Rothblatt, Ph.D., United Therapeutics’ Chairman and Co-Chief Executive Officer stated that their total revenues rose as contrast to the preceding year and they are ongoing to see a growing number of patients being prescribed their pulmonary arterial hypertension (PAH) products. Since its commercial launch last June, Orenitram® is being prescribed to an increasing number of patients and this momentum underscores their belief in the growing clinical support for the use of their orally-administered prostacyclin analogues.
United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension (PAH).
At the end of Monday’s trade, North Atlantic Drilling Ltd. (NYSE:NADL)‘s shares dipped -7.69% to $1.32.
North Atlantic Drilling Ltd. (NADL) declared that it has filed its annual report on Form 20-F for the year ended December 31, 2014. The Annual Report on Form 20-F is accessible from our website www.nadlcorp.com | Investor relations | Financial reports.
The Company’s Annual Report on Form 20-F, may be accessed through the website of the U.S. Securities and Exchange Commission - www.sec.gov. Shareholders may also request a hard copy of the Annual Report, which comprises the Company’s complete 2014 audited merged financial statements, free of charge, by sending an email to: [email protected].
North Atlantic Drilling Limited operates as an offshore drilling services contractor in the North Atlantic region. The company provides harsh environment offshore drilling services to the oil and gas industry primarily in Norway and the United Kingdom.
Tekmira Pharmaceuticals Corp (NASDAQ:TKMR), ended its Monday’s trading session with -7.63% loss, and closed at $17.32.
Tekmira Pharmaceuticals Corp (TKMR) declared that it will hold a conference call and webcast on Wednesday, May 6, 2015 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and first quarter financial results.
Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
